Neuropeptide Receptors: Novel Targets for HIV-AIDS TherapeuticsReport as inadecuate




Neuropeptide Receptors: Novel Targets for HIV-AIDS Therapeutics - Download this document for free, or read online. Document in PDF available to download.

1

Department of Medicine, University of Toronto, Toronto, Ontario M5G 2M1, Canada

2

Department Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5G 2M1, Canada

3

Research & Development, Toronto Immunology Hub, Canadian Blood Services, Toronto, Ontario M5G 2M1, Canada





Abstract The vasoactive intestinal peptide-pituitary adenylyl cyclase-activating polypepetide VPAC receptors are important for many physiologic functions, including glucose homeostasis, neuroprotection, memory, gut function, modulation of the immune system and circadian function. In addition, VPAC receptors have been shown to function in vitro to modulate the infection of HIV by a signal transduction pathway that appears to regulate viral integration. In this article, the affects of VPAC stimulation on HIV infection will be reviewed and approaches for the development of HIV-AIDS therapeutics that target these receptors will be described. Novel HIV-AIDS therapeutics are urgently required to stem the continued spread of this disease, particularly in underdeveloped countries. Drug design to inhibit signaling through VPAC1 and stimulate signaling through VPAC2 could lead to alternative therapies for the treatment and-or prevention of HIV-AIDS. View Full-Text

Keywords: neuropeptide receptors; HIV-AIDS; VPAC1; VPAC2; HIV therapeutics neuropeptide receptors; HIV-AIDS; VPAC1; VPAC2; HIV therapeutics





Author: Donald R. Branch 1,2,3

Source: http://mdpi.com/



DOWNLOAD PDF




Related documents